AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05615415 — intervention group
Intervention type: DRUG
Intervention: MRI Tracer
Description: Injected via intravenous catheter during PET-MR scanning.
Study NCT05615415 — intervention group
Intervention type: DEVICE
Intervention: 3T PET/MRI
Description: Used to evaluate neuroinflammation and cerebrovascular measures. Some MRI image acquisitions will employ work in progress (WIP) sequences, including ASL (Arterial Spin Labeling), Diffusion and T2-weighted EPI (DT2W), Golden-angle radial sparse parallel (GRASP) DCE-MRI, and Magnetization Transfer (MT) imaging.
Study NCT06305884 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bioelectric Impedance Analysis
Description: Undergo BI
Study NCT06305884 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Pedal an exercise bike
Study NCT06305884 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Photoplethysmography
Description: Undergo PPG
Study NCT06305884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05464745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PERINDOPRES® DUO 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets
Description: Oral, generic fixed-dose combination of perindopril tert-butylamine (angiotensin-converting-enzyme inhibitor for the treatment of high blood pressure and heart failure) and indapamide (thiazide-like diuretic used in the treatment of hypertension and decompensated heart failure)
Study NCT05464745 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Noliterax® 10 mg/2.5 mg 10 mg perindopril arginine / 2.5 mg indapamide film-coated tablets
Description: Oral, innovative fixed-dose combination of perindopril arginine (angiotensin-converting-enzyme inhibitor for the treatment of high blood pressure and heart failure) and indapamide (thiazide-like diuretic used in the treatment of hypertension and decompensated heart failure)
Study NCT05030727 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: record of pNGAL
Description: Preoperative (0.hour baseline), postoperative 24.,48. BUN, Creatinine, Lactate values in the blood of the patients at 1 hour, and for plasma NGAL, blood samples will be taken at the preoperative, postoperative 6th and 24th hours. And the results will be recorded.
Study NCT05892887 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% Injectable Solution
Description: Bilateral ultrasound guided in erector spinae plane block by bupivacaine 0.25%
Study NCT05506280 — intervention group
Intervention type: PROCEDURE
Intervention: blood prolactin levels
Description: The extraction technique was performed by venipuncture in 110 veins located in the antecubital area with a 21G butterfly nut with a Vacutainer Safety 111 Lok@ adapter, a 2.5x45cm latex venous compressor and a tube with separating gel 112 (yellow cap)
Study NCT05132803 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HPV 16 TA-CIN
Description: No dose escalation or reduction
Study NCT05330910 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy with concomitant hiatal hernia repair arm
Description: Surgical technique will be standardized and will be performed by the study team. The bougie size for the LSG will be 40Fr, and a standard 5-port LSG will be performed. Standard protocolized postoperative recovery for all bariatric patients will be employed, including liquid diet with vitamins for the first 2 weeks postoperatively, followed by introduction of solid foods after. A hiatal dissection will also be performed during initial surgery, followed by a cruroplasty with Ethibon 0 sutures, in an interrupted manner.
Study NCT05330910 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy arm
Description: Surgical technique will be standardized and will be performed by the study team. The bougie size for the LSG will be 40Fr, and a standard 5-port LSG will be performed. Standard protocolized postoperative recovery for all bariatric patients will be employed, including liquid diet with vitamins for the first 2 weeks postoperatively, followed by introduction of solid foods after.
Study NCT05504876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam Syrup
Description: Administered Midazolam Syrup 5 mg orally once daily in fed state;
Study NCT05504876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC74647PA
Description: Administered HEC74647PA 100 mg orally once daily in fed state;
Study NCT05504876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC110114
Description: Administered HEC110114 600 mg orally once daily in fed state;
Study NCT04655196 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SOLUS-D + weekly feedback by a coach
Description: internet-based self-help
Study NCT04655196 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SOLUS-D + weekly automated messages
Description: internet-based self-help
Study NCT05391178 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lumiton yarn sleeve
Description: Sleeve made from patented technology embedded in synthetic yarns that harnesses the sun's energy and generates red and near-infrared light - elevating apparel
Study NCT05391178 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lumiton yarn hat
Description: Hat made from patented technology embedded in synthetic yarns that harnesses the sun's energy and generates red and near-infrared light - elevating apparel
Study NCT05391178 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lumiton yarn shirt
Description: Shirt made from patented technology embedded in synthetic yarns that harnesses the sun's energy and generates red and near-infrared light - elevating apparel
Study NCT04868552 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-hospital naloxone education
Description: a 5-10 minute pre-hospital education module teaching patients and support persons how and when to administer naloxone
Study NCT05980884 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-carnitine
Description: Participants are required to take a capsule containing 500mg L-carnitine/day continuous for 7-10 days.
Study NCT05559567 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Orthokeratology
Description: The use of a specialty GP contact lens to temporarily correct myopia
Study NCT04414735 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extracorporeal Photopheresis
Description: Infusion of autologous cellular products exposed to ultraviolet light (UV), in the presence of a photosensitizer. The cellular product is obtained through leucopheresis and its subsequent exposure to 8-methoxypsoralen (8-MOP) and irradiation with UV-A light.
Study NCT06391632 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Revised Cardiac Risk Index
Description: The Revised Cardiac Risk Index (RCRI) attempts to estimate the likelihood of cardiac complications during hospitalization in patients undergoing noncardiac surgery.The Frailty Index is a commonly used tool in clinical practice to assess the degree of frailty in patients.The Quality of Recovery-15 scale (QoR-15) is an easy-to-use score for assessing the quality of post-operative recovery.
Study NCT04925648 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dasatinib
Description: Dasatinib 100mg once daily orally for 14 Days
Study NCT04925648 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Darolutamide
Description: Darolumatide 600 mg twice daily orally for 14 Days
Study NCT05776563 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Nutrition visits
Description: Participants will receive exercise and dietary counseling from a nutritionist and registered dietician with extensive experience with diabetes and obesity every 2 weeks during the 12 wee
Study NCT05776563 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Intensification of diabetes regimen
Description: Patient will meet every 2 weeks in person or have regular phone calls with an endocrinologist to review glucose control and intensification of the diabetes regimens. Will follow the general strategies outlined in the Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Study NCT05776563 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Continuous glucose monitor (CGM)
Description: Individuals with uncontrolled T2DM will be asked use a CGM during the 12 week intervention, to monitor glucose control. Target blood glucose levels will be between 80-130 mg/dl before meals and \< 180 mg/dl at bedtime. Individuals not at goal with glycemic targets will undergo intensification of their regimen. Throughout the study, individuals will be contacted via telephone, email or through additional clinic visits as deemed necessary for maintenance of glycemic control.
Study NCT05122702 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: modified Shenling Baizhu San
Description: modified Shenling Baizhu San granules, twice daily for 12 weeks.
Study NCT05122702 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo granules, twice daily for 12 weeks.
Study NCT04685239 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: dual mobility cup
Description: The use of a Sunfit dual mobility cup
Study NCT04685239 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: unipolar cup
Description: The use of a TMT cup
Study NCT04457622 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auditory perception tasks in healthy participants
Description: The participants complete auditory perception tasks while EEG, and MEG record brain signals (primary outcome measure). The tasks acquire behavioral responses with button presses (secondary outcome measure).~All analyses are intra-subject (no analyses are between-subject).
Study NCT05451485 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood speckle tracking
Description: Blood speckle tracking measurements will be acquired of the carotid artery and superficial femoral artery
Study NCT05451485 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound particle Imaging Velocimetry
Description: Ultrasound particle imaging velocimetry will be acquired of the carotid artery and superficial femoral artery
Study NCT05451485 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 4D flow MRI
Description: 4D flow MRI will be acquired of the carotid artery and superficial femoral artery
Study NCT05451485 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Conventional duplex
Description: Conventional duplex measurements will be acquired of the carotid artery and superficial femoral artery
Study NCT04734197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
Description: combination of a topical immunosuppressant and a topical corticosteroid solution
Study NCT04734197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolic Acid 0.1%
Description: topical immunosuppressant
Study NCT04734197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolic Acid 0.3%
Description: topical immunosuppressant
Study NCT04734197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Betamethasone Sodium Phosphate 0.01%
Description: topical corticosteroid solution
Study NCT04734197 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator: Vehicle
Description: topical vehicle solution
Study NCT04734197 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclosporine 0.05% Ophthalmic Emulsion
Description: topical ophthalmic emulsion
Study NCT04734197 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lifitegrast 5% Ophthalmic Solution
Description: topical ophthalmic solution
Study NCT05845697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trigger point dry needling
Description: Filiform needle that pierces the skin and is inserted into an identified trigger point in the muscle
Study NCT05845697 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham dry needling
Description: A validated sham dry needle that is blunted on the end and does not pierce the skin
Study NCT05378009 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: relaxation and physical activity
Description: This FD women group will include 30 females who will be treated for 8 weeks with oral proton pump inhibitors (taken one time daily with 40 mg pantoprazole-tablet dose), Benson relaxation daily sessions (twenty minutes at morning time and another 20 minutes at the evening time), physical activity ( five session per the week conducted on treadmill, 30 minutes in the first treatment month and 40 minutes in the second treatment month)
Study NCT05378009 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: relaxation
Description: This FD women group will include 30 females who will be treated for 8 weeks with oral proton pump inhibitors (taken one time daily with 40 mg pantoprazole-tablet dose) and Benson relaxation daily sessions (twenty minutes at morning time and another 20 minutes at the evening time)
Study NCT06427551 — intervention group
Intervention type: DRUG
Intervention: Ropivacaine
Description: The local anesthetic was dosed on the patient's weight (50-59kg: 120mg, 60-61kg: 140mg, 70-79kg: 160mg, ≥80kg: 180mg)
Study NCT05282056 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CAD analysis
Description: CAD shows the radiologist automatically delineated areas of potential COVID-19 affection, together with an overall lung affection percentage.
Study NCT05680116 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MYOVOLT (MyovoltTM, Myovolt Limited, Christchurch, New Zealand ) wearable vibration therapy device
Description: Patients will wear Myovolt shoulder device twice a week and each session will continue 30minutes. This therapy will apply during the radiotherapy process. The device will be applied on the bare skin of the shoulder area. The first 10 minutes of the 30 minutes will be intermittent vibration, the other 20 minutes will be done in the sinusoidal vibration program. Both programs will be in the range of 20-100 Hz.
Study NCT05680116 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home based exercise
Description: Patients will do home based exercise during the radiotherapy process. 5 days a week. 2 sessions a day, each exercise will be 10x2 repetitions
Study NCT04631094 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The group holding the serrated ball in the hand on the extremity from which venous blood will be taken
Description: Children in the experimental groups will squeeze the serrated ball during the blood draw.
Study NCT04631094 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The group holding the serrated ball in the hand on the opposite side of the extremity from which venous blood will be taken.
Description: Children in the experimental groups will squeeze the serrated ball during the blood draw.
Study NCT05861505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neoadjuvant systemic therapy (CAPOX+/-B FOLFOX+/-B FOLFIRI+/-B)
Description: Standard first line systemic treatment:~CAPOX+/-B FOLFOX+/-B FOLFIRI+/-B~CAPOX 4x (12 weeks) FOLFOX/FOLFIRI 6x (12 weeks)~Maximum 4 cycles of CAPOX or 6 cycles of FOLFOX/FOLFIRI +/- bevacizumab regardless of the location of primary tumor or RAS/BRAF mutation
Study NCT05861505 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Repeat local treatment
Description: Choice of repeat local treatment is to the discretion of the local investigator, and may be selected on a per patient basis.~The safety, feasibility and preferred type of surgical resection(s) is at the discretion of the liver surgeon (whether or not combined with thermal ablation).~The safety, feasibility and preferred type of thermal ablation(s) is at the discretion of the interventional radiologist (whether or not combined with surgical resection).
Study NCT05861505 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Repeat local treatment
Description: Choice of repeat local treatment is to the discretion of the local investigator, and may be selected on a per patient basis.~The safety, feasibility and preferred type of surgical resection(s) is at the discretion of the liver surgeon (whether or not combined with thermal ablation).~The safety, feasibility and preferred type of thermal ablation(s) is at the discretion of the interventional radiologist (whether or not combined with surgical resection).
Study NCT05650034 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Elective nodal de-escalation arm
Description: Omission of elective nodal irradiation in N0 hemi-neck of well lateralized H\&N SCCs ( pN0 or by PETCT). Dose de-escalation of elective nodal irradiation in N0 hemi-neck of midline H\&N SCCs ( pN0 or by PETCT).
Study NCT06183008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin
Description: Each patient will during the 30-week trial period get 3 IVIG courses (each total dose 2g/kg) for three consecutive days
Study NCT06183008 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Each patient will during the 30-week trial period get 3 placebo courses (each 0.9% saline similar volume) for three consecutive days
Study NCT04631094 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The group holding a smooth ball in the hand on the extremity from which venous blood will be taken
Description: Children in the experimental groups will squeeze the smooth ball during the blood draw.
Study NCT05182047 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Butamirate citrate
Description: Butamirate citrate syrup will be administered orally.
Study NCT04631094 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The group holding a smooth ball in the hand opposite the extremity from which venous blood will be taken.
Description: Children in the experimental groups will squeeze the smooth ball during the blood draw.
Study NCT05510271 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: White Noise
Description: Orhan OSMAN's song Don't Let Your Baby Cry-2 from the Kolik album was used.
Study NCT05510271 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yakson Touch
Description: In order to transfer the Ki energy to the baby, he took a deep breath and gathered the universal energy in his palms, intending the baby's well-being and healing. The researcher applied the Yakson touch by covering the abdomen and chest of the newborn with his right hand (dominant hand) while the newborn was in the supine position, and supported the baby's back and hips with his left hand.
Study NCT05641389 — intervention group
Intervention type: OTHER
Intervention: Monitoring
Description: Participants will be monitored for alcohol use.
Study NCT05182047 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sinecod
Description: Sinecod syrup will be administered orally.
Study NCT05101200 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Dose Neural Mobilization Technique
Description: Patients in This Group will receive the high dose neural mobilization along with hot pack, strengthening exercises, Neural mobilization technique (slump, sciatic). Participants in the NMG will be asked to actively perform knee extension, ankle dorsiflexion, and head extension in a slumped posture (body and neck semi flexion) followed by simultaneous ankle plantar flexion together with knee and head flexion, Hot pack for 15 minutes, Strengthening exercises of muscles with 10 /8sets. Strengthening exercises of quadriceps with10 rep/8sets, Static stretching exercise for hamstring muscle with 10 rep/8sets, Group A will be given session of 40 min/day, 2 days/week for 4 weeks.
Study NCT05101200 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Dose Neural Mobilization Technique
Description: Patients in this Group will receive the same treatment as group A but with less intensity and low dosage. Hot pack: 15 minutes, Strengthening exercises of muscles with 10 rep/4sets, Static stretching exercise for hamstring muscle with 10 rep/4sets. Group B will be given session of 40min/day, 2 days/week for 4weeks.
Study NCT05592860 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobile application
Description: participants in intervention group will use smart phone application and update glucose level and investigator will adjust the insulin accordingly
Study NCT05592860 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Daily Diary
Description: participants will use daily diary to record glucose level
Study NCT04902300 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: evaluation of internet addiction
Study NCT06500754 — intervention group
Intervention type: OTHER
Intervention: Ultra-strict gluten-free diet
Description: ultra-strict gluten-free diet (avoiding traces and contamination) under dietitian supervision
Study NCT06452264 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: game-like computerized activities
Description: game-like computerized activities
Study NCT06452264 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: game-like computerized activities
Description: game-like computerized activities
Study NCT06270758 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CT scan at the femur
Description: Additional CT scan which is not part of the standard clinical path
Study NCT05389449 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Danicopan
Description: Oral tablet
Study NCT05947292 — intervention group
Intervention type: PROCEDURE
Intervention: Ultrasound-Guided Fascia Iliaca Compartment Nerve Block
Description: Patient's who receive this intervention will have an ultrasound-guided fascia iliaca compartment nerve block performed in the Emergency Department.